BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17709658)

  • 1. Immunohistochemical expression of platelet growth factor and vascular endothelial growth factor in patients with melanoma with and without redness (Brenner sign).
    Mashiah J; Wohl Y; Barnea Y; Schneebaum S; Gat A; Misonzhnik-Bedny F; Brenner S
    Arch Dermatol; 2007 Aug; 143(8):1001-4. PubMed ID: 17709658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in cytokine levels in melanoma patients with and without redness (Brenner sign).
    Mashiah J; Brenner S; Pessach Y; Barak V; Schachter J
    Anticancer Res; 2009 May; 29(5):1793-6. PubMed ID: 19443406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma.
    Ribatti D; Nico B; Floris C; Mangieri D; Piras F; Ennas MG; Vacca A; Sirigu P
    Oncol Rep; 2005 Jul; 14(1):81-4. PubMed ID: 15944771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous anaplastic large cell lymphoma associated with vascular endothelial growth factor arising from a burn scar.
    Morihara K; Takenaka H; Morihara T; Kishimoto S
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S103-5. PubMed ID: 17938017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
    Einspahr JG; Thomas TL; Saboda K; Nickolof BJ; Warneke J; Curiel-Lewandrowski C; Ranger-Moore J; Duckett L; Bangert J; Fruehauf JP; Alberts DS
    Cancer; 2007 Dec; 110(11):2519-27. PubMed ID: 17932890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.
    Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M
    Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the biological function of vascular endothelial cells in the hypertrophic scar].
    Wang XQ; Lu SL; Mao ZG; Liu YK
    Zhonghua Shao Shang Za Zhi; 2007 Jun; 23(3):219-21. PubMed ID: 18019066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased lengthening rate decreases expression of fibroblast growth factor 2, platelet-derived growth factor, vascular endothelial growth factor, and CD31 in a rat model of distraction osteogenesis.
    Schiller JR; Moore DC; Ehrlich MG
    J Pediatr Orthop; 2007 Dec; 27(8):961-8. PubMed ID: 18209624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-1, but not platelet-derived growth factor-AB, is a cooperative stimulator of vascular endothelial growth factor A-accelerated endothelial cell scratch closure.
    Alter A; Schmiedeck D; Fussnegger MR; Pries AR; Freesmeyer WB; Zakrzewicz A
    Ann Vasc Surg; 2009 Mar; 23(2):239-45. PubMed ID: 18973985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
    Nam DH; Oh J; Roh JH; Huh K
    Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
    Eskens FA; Steeghs N; Verweij J; Bloem JL; Christensen O; van Doorn L; Ouwerkerk J; de Jonge MJ; Nortier JW; Kraetzschmar J; Rajagopalan P; Gelderblom H
    J Clin Oncol; 2009 Sep; 27(25):4169-76. PubMed ID: 19636022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.
    Chua R; Setzer S; Govindarajan B; Sexton D; Cohen C; Arbiser JL
    J Am Acad Dermatol; 2009 May; 60(5):758-66. PubMed ID: 19389518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of thymosin beta10 and its role in non-small cell lung cancer.
    Gu Y; Wang C; Wang Y; Qiu X; Wang E
    Hum Pathol; 2009 Jan; 40(1):117-24. PubMed ID: 18789485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
    Depasquale I; Thompson WD
    Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
    Grundtman C; Tham E; Ulfgren AK; Lundberg IE
    Arthritis Rheum; 2008 Oct; 58(10):3224-38. PubMed ID: 18821695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma.
    Rivera RS; Nagatsuka H; Siar CH; Gunduz M; Tsujigiwa H; Han PP; Katase N; Tamamura R; Ng KH; Naomoto Y; Nakajima M; Nagai N
    Oncol Rep; 2008 Mar; 19(3):657-61. PubMed ID: 18288398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study.
    Dong P; Li X; Yu Z; Lu G
    J Laryngol Otol; 2007 Dec; 121(12):1177-83. PubMed ID: 17888194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.